Notable Facts
→Chief Research Officer at Travere Therapeutics since February 2017, previously SVP R&D
→Over 25 years of experience in biopharmaceutical industry
→Previously VP Clinical Development at Ardea Biosciences (AstraZeneca subsidiary)
→Former VP and site head for R&D at Amylin Pharmaceuticals
→Ph.D. in Pharmacology from Pennsylvania State University
→Postdoctoral training at University of Michigan
→500+ LinkedIn connections
→Oversees discovery, translational research, regulatory affairs, and CMC operations
→Recent stock transactions totaling over $2.4M indicating senior executive compensation